Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- firm, nontender, red or pink-to-violaceous or skin-colored papule or subcutaneous nodule
- rapidly growing lesion
Outros fatores diagnósticos
- enlarged lymph nodes
- ulceration or bleeding cutaneous lesion
- small papules or nodules surrounding a primary lesion
Fatores de risco
- cumulative ultraviolet (UV) exposure
- immunosuppression
- advancing age
- male sex
- white skin
- Merkel cell polyomavirus (MCPyV) infection with oncogenic transformation
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- biopsy and histopathologic assessment
- dermoscopy
Investigações a serem consideradas
- lymph node ultrasound
- whole-body PET scan
- CT scan with contrast chest/abdomen/pelvis (± neck)
- brain MRI
- fine-needle aspiration or core biopsy
- sentinel lymph node biopsy (SLNB)
- Merkel cell polyomavirus serology
Novos exames
- circulating tumor DNA (ctDNA) analysis
Algoritmo de tratamento
localized disease: stage I or II (T-any cN0 M0)
regional disease: stage IIIA
regional disease: unknown primary tumor with clinically apparent nodal disease
regional disease: stage IIIB
distant metastatic disease: stage IV
Colaboradores
Autores
Kelly Harms, MD, PhD
Associate Professor of Dermatology
Michigan Medicine
University of Michigan
Ann Arbor
MI
Declarações
KH is a panel member for NCCN guidelines on Merkel cell carcinoma. She serves as Chair of Professionalism and Ethics for the Michigan Dermatological Society Board of Directors. KH is married to Paul Harms, a co-author of research on Merkel cell carcinoma.
Alison Lee, MD, MHS
Clinical Fellow
Department of Dermatology
Michigan Medicine
University of Michigan
Ann Arbor
MI
Declarações
AL declares that she has no competing interests.
Revisores
Isaac Brownell, MD, PhD
Senior Investigator
Dermatology Branch
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institutes of Health (NIH)
Bethesda
MD
Declarações
IB declares that he has no competing interests.
Zoe Venables, MbChB, MMedSci, MRCP
Clinical Associate Professor and Consultant Dermatologist
Norfolk and Norwich University Hospitals NHS Foundation Trust
Norwich
UK
Declarações
ZV declares that she has no competing interests.
Peer reviewer acknowledgements
BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.
Disclosures
Peer reviewer affiliations and disclosures pertain to the time of the review.
Referências
Principais artigos
National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: Merkel cell carcinoma [internet publication].Texto completo
Gauci ML, Aristei C, Becker JC, et al; the European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO), and the European Organization for Research and Treatment of Cancer (EORTC). Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline - update 2022. Eur J Cancer. 2022 Aug:171:203-31.Texto completo Resumo
Lugowska I, Becker JC, Ascierto PA, et al; ESMO Guidelines Committee. Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. ESMO Open. 2024 May;9(5):102977.Texto completo Resumo
Silk AW, Barker CA, Bhatia S, et al. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer. J Immunother Cancer. 2022 Jul;10(7):e004434.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Basal cell carcinoma (BCC)
- Squamous cell carcinoma (SCC) of the skin
- Amelanotic/hypomelanotic melanoma
Mais Diagnósticos diferenciaisDiretrizes
- NCCN clinical practice guidelines in oncology: Merkel cell carcinoma
- Merkel-cell carcinoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up
Mais DiretrizesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal